AU
GNTX icon

AlphaGrep UK’s Gentex GNTX Stock Holding History

AlphaGrep UK’s Portfolio GNTX Stock Details GNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,119
Closed -$305K – 844
2025
Q4 		$305K Buy
+13,119
New +$316K 0.1% 419

Other funds holding GNTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AlphaGrep UK's GNTX Position: Q1 2026 in Review

AlphaGrep UK sold out of Gentex (GNTX) in Q1 2026, closing a stake of 13,119 shares — an estimated $305K sold.

AlphaGrep UK first reported a position in GNTX in Q4 2025 and held it in 1 quarter. The position peaked at $305K in Q4 2025. 504 funds tracked by Wall St. Rank hold GNTX as of Q1 2026.

  • AlphaGrep UK reported no remaining Gentex position as of Q1 2026 after selling out during the quarter.
  • AlphaGrep UK sold 13,119 Gentex shares in Q1 2026, an estimated $305K.
  • AlphaGrep UK first reported a position in Gentex in Q4 2025 and held it in 1 quarter.
  • AlphaGrep UK's Gentex position peaked at $305K in Q4 2025.
  • 504 funds tracked by Wall St. Rank held Gentex as of Q1 2026.

Based on AlphaGrep UK's 13F filing for Q1 2026, filed 13 Aug 2026.